International Clinical Trial: Immune Checkpoint Inhibitors Combined with R-DA-EPOCH versus R-DA-EPOCH Alone as First-Line Treatment for Treatment-Naive HIV-Associated Diffuse Large B-Cell Lymphoma: A Multicenter, Bidirectional Cohort Study

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132184) titled 'Immune Checkpoint Inhibitors Combined with R-DA-EPOCH versus R-DA-EPOCH Alone as First-Line Treatment for Treatment-Naive HIV-Associated Diffuse Large B-Cell Lymphoma: A Multicenter, Bidirectional Cohort Study' on Sept. 10.

Study Type: Observational study

Study Design: Sequential

Primary Sponsor: Southern Medical University Southern Hospital

Condition: Diffuse large Bcell lymphoma (DLBCL) associated with human immunodeficiency virus (HIV) infection

Intervention: ICICombined Group:None

Recruitment Status: Not Recruiting

Phase: 4

Date of First Enrollment: 2026-09-15

Target Sample Size: ICICombined Gr...